Bicycle Therapeutics plc (BCYC)

Bicycle Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Bicycle Therapeutics stock have an average target of 29.14, with a low estimate of 15 and a high estimate of 48. The average target predicts an increase of 296.46% from the current stock price of 7.35.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15	$29.14	$30	$48
Change	+104.08%	+296.46%	+308.16%	+553.06%

Analyst Ratings

The average analyst rating for Bicycle Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	3	3	3	2	2	2
Buy	4	4	4	4	4	4
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ami Fadia Needham	Needham	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+308.16%	Apr 9, 2025
Ami Fadia Needham	Needham	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+308.16%	Mar 11, 2025
Reni Benjamin Citizens Capital Markets	Citizens Capital Markets	Buy Reiterates $26	Buy	Reiterates	$26	+253.74%	Feb 26, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $33	Strong Buy	Reiterates	$33	+348.98%	Feb 26, 2025
Ami Fadia Needham	Needham	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+308.16%	Feb 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

32.29M

Decreased by -8.47%

from 35.28M

Revenue Next Year

32.37M

Increased by 0.27%

from 32.29M

EPS This Year

-3.51

from -2.90

EPS Next Year

-4.18

from -3.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	10.39M	11.70M	14.46M	26.98M	35.28M	32.29M	32.37M	98.67M
Revenue Growth	-24.72%	12.58%	23.65%	86.52%	30.76%	-8.47%	0.27%	204.77%
EPS	-2.66	-2.67	-3.80	-5.08	-2.90	-3.51	-4.18	-3.58
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	16	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	63.0M	75.6M	225.8M
Avg	32.3M	32.4M	98.7M
Low	n/a	n/a	18.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	78.6%	134.1%	597.3%
Avg	-8.5%	0.3%	204.8%
Low	-	-	-44.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.92	-3.43	-2.84
Avg	-3.51	-4.18	-3.58
Low	-3.92	-5.24	-4.90

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.